Richard Kivel

Richard Kivel

Managing Director at GrayBella Capital

Richard serves as Managing Director of GrayBella Capital, a European mid-stage venture capital firm investing in technology and healthcare companies.

Richard has been a private investor, CEO, COO & Chairman of both publicly listed and private companies. He also served as a Senior Management Executive at Bridgewater Associates, the world’s largest hedge fund with $160B in global investments

Richard is a guest lecturer on Global Entrepreneurship and Venture Investing at MIT and other universities in Europe and Russia. He serves as a Trustee of the Bankinter Foundation of Innovation, a global technology Think-Tank based in Spain & Portugal and is a member of the Portugal Ventures – Expert Network.

Richard is a Judge for the MIT $100K Entrepreneurship Competition and is engaged with the MIT Deshpande Center, MIT Koch Institute for Cancer Research and other organizations focused on health, technology and innovation. Former Chairman & President: MIT Enterprise Forum Global.

To know more

Entrepreneurship with Frugal AI: Low-Cost Innovation for SMEs

Entrepreneurship with Frugal AI: Low-Cost Innovation for SMEs

Algorithms that are lightweight and accessible, allowing SMEs and entrepreneurs to apply artificial intelligence without relying on large models or expensive infrastructure. When talking about artificial intelligence, the conversation often revolves around giants like ChatGPT, Gemini or Claude—models with billions of parameters that require powerful data centers and budgets only accessible to large corporations. However, […]

Read more
Conrad Wolfram: “If we teach as if computers didn’t exist, we are failing”

Conrad Wolfram: “If we teach as if computers didn’t exist, we are failing”

The expert advocates for a radical change in math education: less manual calculation, more computational thinking, and real-world connection.

Read more
Journey inside the brain 

Journey inside the brain 

If we can understand the brain, we will be able to address diseases and disorders that have so far eluded us.

Read more